Downstream Processing Featured Articles

  1. New Nanoparticles Shrink Tumors In Mice 8/16/2012

    MIT researchers have developed RNA-delivering nanoparticles that allow for rapid screening of new drug targets in mice. In their first mouse study, done with researchers at Dana-Farber Cancer Institute and the Broad Institute, they showed that nanoparticles that target a protein known as ID4 can shrink ovarian tumors.  

  2. Acceleron Initiates Phase 2 Study Of ACE-536 To Treat Patients With Beta-Thalassemia 3/7/2013

    Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, recently announced the initiation of a phase 2 study of its novel, investigational protein therapeutic, ACE-536, to treat patients with beta-thalassemia, a genetic hematologic disorder causing chronic and life-threatening anemia and serious complications affecting the spleen, liver and heart.

  3. New Injectable Gels Toughen Up After Entering The Body 11/16/2012

    Gels that can be injected into the body, carrying drugs or cells that regenerate damaged tissue, hold promise for treating many types of disease, including cancer. However, these injectable gels don’t always maintain their solid structure once inside the body. By Anne Trafton

  4. Putting Capillary Electrophoresis to Work 3/8/1999
    It's been over 10 years since the first commercial instrument for capillary electrophoresis (CE) was introduced with a fanfare and a list of promises to revolutionize the world of separation science...
  5. Millipore Unveils Mobius FlexReady Solutions At INTERPHEX 2009 3/17/2009
    Billerica, Massachusetts-Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, announces the launch of its Mobius FlexReady Solutions.
  6. Success Of Engineered Tissue Depends On Where It's Grown 8/14/2012

    Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than others. By Anne Trafton

  7. Fragile X Makes Brain Cells Talk Too Much 2/20/2013

    The most common inherited form of mental retardation and autism, fragile X syndrome, turns some brain cells into chatterboxes, scientists at Washington University School of Medicine in St. Louis report. By Michael C. Purdy

  8. Lpath Receives First U.S. Patent For Anti-LPA Antibody, Lpathomab 4/25/2012

    Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that it has been issued a key patent protecting Lpathomab™, a monoclonal antibody against lysophosphatidic acid (LPA).

  9. NIH Researchers Implicate Unique Cell Type In Multiple Sclerosis 8/1/2012

    Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). 

  10. New CU-Boulder Discoveries Hold Promise For Treatment Of Hepatitis B Virus Infection 10/22/2012

    A University of Colorado Boulder-led team has discovered two prime targets of the Hepatitis B virus in liver cells, findings that could lead to treatment of liver disease in some of the 400 million people worldwide currently infected with the virus.